Pharmafile Logo
Pharmafocus logo
Advanced Search

Manufacturing and Production

Showing 15 posts of 5860 posts found.

unnamed_1

FDA grants Emergency Use Authorization to Eli Lilly’s antibody drug to treat COVID-19

November 10, 2020 Manufacturing and Production

The FDA has granted Emergency Use Authorization (EUA) to Eli Lilly’s antibody drug bamlanivimab for the treatment of COVID-19 patients …
News
flu_vaccination_grippe_5115654021

Sinovac COVID-19 trial suspended in Brazil due to severe adverse event

November 10, 2020 Manufacturing and Production Brazil, COVID, COVID Vaccine, coronavirus

Brazil’s health regulator Anvisa has suspended a clinical trial for China’s Sinovac coronavirus vaccine due to the occurrence of a …
News
astrazeneca_sign_sky

Argentina secures 22 million COVID-19 vaccine doses from AstraZeneca and Oxford Uni

November 9, 2020 Manufacturing and Production, Sales and Marketing Argentina, AstraZeneca, COVID-19, Vaccine

AstraZeneca has committed to an agreement to deliver 22 million doses of its COVID-19 vaccine candidate, co-developed in partnership with …
News
shutterstock_2

Australia secures a further 50m COVID-19 vaccine doses from Novavax and Pfizer/BioNTech

November 5, 2020 Manufacturing and Production Australia, COVID-19, Vaccine

Two more COVID-19 vaccine distribution deals have been signed by the Australian Government, reserving a further 50 million doses to …
News
tt

How the US election could affect the pharmaceutical industry

November 4, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Donald Trump, Joe Biden, Trump, US, US election 2020, pharma

The US is one of the most lucrative markets for the pharmaceutical industry. This is a country where a lack of …
Feature
covid_cell_1

Pharmafile.com’s weekly COVID-19 news round-up

November 4, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, GSK, Sanofi, UK, US, remdesivir

As European nations fall one by one back into lockdown, hopes weigh heavily on a vaccine to pave a path …
News
s_pills

Nostrum Laboratories recalls metformin tablets over safety concerns

November 4, 2020 Manufacturing and Production, Research and Development Nostrum laboratories, metformin, recall

Missouri-based Nostrum Laboratories has issued a product recall of its type 2 diabetes drug metformin to the FDA over concerns …
News
regeneron

Regeneron halts Phase 1 study into ultra-rare disease due to patient deaths

November 3, 2020 Manufacturing and Production, Research and Development Regeneron, clinical trials, garetosmab, pharma

Regeneron has slammed the brakes on its Phase 1 trial of garetosmab in the treatment of the ultra-rare condition fibrodysplasia …
News

UCB Pharma’s bimekizumab improves skin clearance over Humira in plaque psoriasis

November 3, 2020 Manufacturing and Production, Research and Development UCB Pharma, bimekizumab, pharma

In recent Phase 3 study data presented European Academy of Dermatology and Venereology Congress last weekend, UCB Pharma reported that …
News
covid_cell_1

T-cells respond to COVID-19 six months after infection

November 3, 2020 Manufacturing and Production

There is evidence that human T-cells can respond to coronavirus six months after the body is initially infected, according to …
News
800px-laboratoires_arkopharma_-_chaine_de_conditionnement_remplissage_piluliers_1

Novavax to expand Maryland facility to support global vaccine development

November 3, 2020 Manufacturing and Production

Novavax has announced that it plans to expand its Maryland campus to facilitate the company’s growth as it develops its …
News
tt

How the US election could affect the pharmaceutical industry

November 3, 2020 Manufacturing and Production

The US is one of the most lucrative markets for the pharmaceutical industry. This is a country where a lack of …
News
shutterstock_87495637

AstraZeneca jettisons two heart drugs to Cheplapharm in $400m deal

October 30, 2020 Manufacturing and Production, Medical Communications, Sales and Marketing AstraZeneca, Cheplapharm

AstraZeneca is set to sell the rights to its AT1 subtype angiotensin II receptor antagonist Atacand (candesartan cilexetil) and Atacand …
News
takeda_usa_pharmaceuticals_u

Takeda commits to deliver 50 million doses of Moderna’s COVID-19 vaccine in Japan

October 29, 2020 Manufacturing and Production, Sales and Marketing COVID-19, Japan, Moderna, Takeda, Vaccine

Takeda has made a commitment with Japan’s Ministry of Health, Labor and Welfare (MHLW) to deliver 50 million doses of …
News
vaccination-1215279_960_720

GSK and Sanofi promise 200m COVID-19 vaccines to international COVAX initiative

October 28, 2020 Manufacturing and Production, Research and Development COVAX, COVID-19, GSK, Sanofi

Sanofi and GSK have committed 200 million doses of their adjuvanted recombinant protein-based COVID-19 vaccine to the COVAX Facility, a …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026